The pharmaceutical sector has been making headlines for large-scale layoffs, department closures and clinical trial failures.

There is a federal law, the Genetic Information Nondiscrimination Act (GINA) of 2008, that is supposed to protect Americans from outcomes like these, but experts have noted GINA is far from foolproof.

According to new data from the financial analytics firm Debtwire, 23andMe is among 40 former SPACs that have filed for bankruptcy since 2022. That’s a failure ... with new leadership and a ...

The company filed for bankruptcy after financial challenges over the past few years and a massive data breach in 2023.

Several state attorneys general (AGs) and the Federal Trade Commission (FTC) have begun scrutinizing ancestry tracking company 23andMe following ...

Whether it’s a cyberattack, misinformation caused by AI, executive misbehavior, or a high-profile trial, crises are not a matter of “if” but “when.” And when they happen, leaders must step in and ...

With CEO Anne Wojcicki resigning immediately after the announcement, the company is now looking for new leadership direction amid this significant financial distress. In light of its mounting ...